Green Thumb Industries Inc. (OTCMKTS:GTBIF - Get Free Report)'s share price was up 4.3% on Monday . The company traded as high as $8.17 and last traded at $8.16. Approximately 97,066 shares changed hands during trading, a decline of 80% from the average daily volume of 490,896 shares. The stock had previously closed at $7.82.
Analyst Ratings Changes
Several analysts have recently commented on the company. Zacks Research downgraded Green Thumb Industries from a "hold" rating to a "strong sell" rating in a research note on Friday, October 10th. Canaccord Genuity Group upgraded Green Thumb Industries to a "strong-buy" rating in a research note on Thursday, October 9th. Finally, Benchmark restated a "buy" rating on shares of Green Thumb Industries in a research note on Monday, August 11th. Two analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Buy".
Check Out Our Latest Research Report on GTBIF
Green Thumb Industries Stock Performance
The business has a 50 day moving average price of $8.22 and a two-hundred day moving average price of $6.55. The stock has a market cap of $1.69 billion, a PE ratio of 74.19 and a beta of 1.20.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). Green Thumb Industries had a return on equity of 1.62% and a net margin of 2.51%.The business had revenue of $293.26 million during the quarter, compared to analysts' expectations of $280.66 million. As a group, research analysts anticipate that Green Thumb Industries Inc. will post 0.32 earnings per share for the current year.
About Green Thumb Industries
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.